GENEREX BIOTECHNOLOGY CORP

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$1.1M

160 transactions

Summary

GENEREX BIOTECHNOLOGY CORP is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $329KSales: $453K19 insiders

Date	Insider	Type	Value
2018-12-07	Haines Harold Gray	Buy	$8K
2019-11-16	GLUSKIN ANNA E(CEO & Pres.)	Buy	$5K
2018-12-04	Haines Harold Gray	Buy	$2K
2018-12-04	Haines Harold Gray	Buy	$1K
2018-12-07	Haines Harold Gray	Buy	$309
2018-10-03	Anderson James H Jr.	A	$0
2018-10-03	Centofanti Kevin	A	$0
2018-10-03	Corrao Mark(CFO & Treasurer)	A	$0
2018-10-03	FLETCHER MARK(EVP General Counsel &Secretary)	A	$0
2018-10-03	Lyman Gary Herbert	A	$0
2018-10-03	MCGEE BRIAN	A	$0
2018-10-03	Purcell Richard David Jr.(SVP of Research & Drug Develop)	A	$0
2018-10-03	Ro Andrew(SVP & Chief Investment Officer)	A	$0
2016-02-16	FLETCHER MARK(President & CEO)	M	$0
2016-02-16	FLETCHER MARK(President & CEO)	M	$0
2016-02-16	Brusegard David(Chief Operating Officer)	M	$0
2016-02-16	Brusegard David(Chief Operating Officer)	M	$0
2016-02-09	FLETCHER MARK(President & CEO)	M	$0
2016-02-09	FLETCHER MARK(President & CEO)	M	$0
2016-02-09	FLETCHER MARK(President & CEO)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

GENEREX BIOTECHNOLOGY CORP — Contributions, Lobbying & Contracts | Poliscope